ALEXZANDRIA MAROTTA: Open Payments
NPI 1073895439 · LADY LAKE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 28 payments from 14 companies in 2025. Trend: 2023 $898 · 2024 $650 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 5 | $130 |
| ABBVIE INC. | 4 | $96 |
| E.R. Squibb & Sons, L.L.C. | 4 | $89 |
| EMD Serono, Inc. | 3 | $56 |
| Genmab U.S., Inc. | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Incyte Corporation | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| Eisai Inc. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
Products named: REBLOZYL, VENCLEXTA, OPDUALAG, Epkinly, Fabhalta, OPDIVO, MONJUVI, IMFINZI.
Industry payments across FL — which companies pay providers there.
